# OnCo record ar-signaling (pathway). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/pathways/ar-signaling/>
  a schema:BioChemEntity ;
  onco:kind "pathway" ;
  schema:identifier "ar-signaling" ;
  schema:name "Androgen receptor signalling"@en ;
  schema:description "Androgen receptor signalling is prostate cancer's engine. Testosterone becomes DHT, binds the androgen receptor, and drives growth genes. Castration removes the fuel; newer pills block the receptor or the enzyme that makes fuel inside the tumour."@en ;
  schema:url <https://onco.cc/pathways/ar-signaling/> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Androgen_receptor> ;
  owl:sameAs <http://www.wikidata.org/entity/Q416601> ;
  schema:citation <https://en.wikipedia.org/wiki/Androgen_receptor> ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/tnbc/> ;
  onco:technologies <https://onco.cc/technologies/androgen-deprivation/> ;
  onco:targets <https://onco.cc/targets/androgen-receptor/>, <https://onco.cc/targets/parp/>, <https://onco.cc/targets/akt/>, <https://onco.cc/targets/psma/> ;
  onco:drugs <https://onco.cc/drugs/capivasertib/>, <https://onco.cc/drugs/olaparib/>, <https://onco.cc/drugs/talazoparib/>, <https://onco.cc/drugs/niraparib/> .